TriSol Medical
Percutaneous Tricuspid Valve Replacement
Startup A Health Tech & Life Sciences Est. 2016
Total Raised
$31.43M
A
Last Round
$1.43M
4 rounds
Investors
3
3 public
Team
2
11-50 employees
Confidence
90/100
News
2
articles
Patents
1
About
Trisol Medical goal is to develop the best-in-class Transcatheter Tricuspid Replacement Valve, which eliminates Tricuspid Regurgitation while preserving the Right Ventricle function. Trisol Medical device concept and unique design was created out of deep understanding and knowledge of the unmet need of treating Tricuspid Valve insufficiency. Trisol device is a Transcatheter Tricuspid Valve Replacement, which is implanted easily and intuitively. Trisol valve is constructed out of nitinol frame with specially designed dome-shaped leaflet. Its unique design provides a comprehensive solution to eliminating Tricuspid Regurgitation while preserving the Right Ventricle function. Trisol Valve is suited to all severe Tricuspid Regurgitation patients.
Classification
Sector
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Core Technology
Materials & SubstancesImplants
Target Customer
Healthcare & Life SciencesHealthcareProviders
Business Model
B2B
Tags
valvescardiologycardiovascularmedical-deviceshospitals
Funding & Events
Oct 2018
A Round $2.7M
JVC
Jul 2023
Undisclosed Round $1.43M
European Innovation Council
Jul 2016
Non-equity $27.3M
(Lead)
Seed Undisclosed
Alon MedTech Ventures
News (2)
Aug 23, 2023 · www.newswire.ca
growth-positive
Trisol announces successful implants of its Transcatheter Tricuspid Valve in the US
CustomersPartners
Oct 15, 2018 · en.globes.co.il
growth-positive
Heart valve co Trisol Medical raises $2.7m
Investment
Details
Product Stage
R&D
Employees
11-50
Exact Count
25
District
North District
Founded
2016
Registrar
515485944
Crunchbase
trisol-medical
Locations
HaKidma St 7, Yokne'am Illit, Israel
Links
Website
LinkedIn
Admin
Last Update
Sep 14, 2024
Verified by
Jenny Sotnik-Talisman
Missing
markets, not claimed
Team (2)
Ron Davidson
CEO
Eli Benhamou
VP R&D
Internal
Created by
Jenny Sotnik-Talisman (genys30@yahoo.com)
Created
2017-10-30T00:00:00.000Z
Last editor
Yanina Wainscheinker (yanina.wainscheinker@sncentral.org)